ACE and anemia: Lastly, no significant differences were found in the rates of anemia as well as the usage of beta-blockers, ACE inhibitors, angiotensin receptor blockers, spironolactone, statins, aspirin (ASA), and clopidogrel (p > 0.05). The analysis of in-hospital parameters according to maximum NLR groups is detailed in Table 5.